Fig. 5.
Expression of surface antigens/antigen combinations in patients with higher- and lower-risk MDS. a Expression of surface antigens in patients with higher- and lower-risk MDS. b Expression of surface antigen combinations in patients with higher- and lower-risk MDS. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)